Innate Pharma IPHA
NASDAQ IPHA
$1.60 +0.02 (+1.39%)
As of: Oct 21, 2026 · 1:33 PM EDT

Innate Pharma (IPHA) Free Cash Flow (2019)

Updated

Innate Pharma's Free Cash Flow was -$61.25 million in the quarter ended Dec 31, 2025, compared with -$6.95 million a year earlier.

Analysis

Innate Pharma (IPHA) Free Cash Flow (2019) Analysis & Trends

For the year ended Dec 31, 2025, Free Cash Flow at Innate Pharma came in at -$59.45 million.

  • In earlier years, Free Cash Flow was -$7.04 million in the year ended Dec 31, 2024, -$34.84 million in the year ended Dec 31, 2023, -$19.62 million in the year ended Dec 31, 2022 and -$65.81 million in the year ended Dec 31, 2021.
  • The figure for the quarter ended Dec 31, 2025 marks the lowest quarterly Free Cash Flow since the quarter ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Eli Lilly 1,137.36 Bn 1,105.95 Bn 19.71 Bn 7.76 Bn
2 Johnson & Johnson 617.62 Bn 536.15 Bn 17.26 Bn 7.30 Bn
3 AbbVie 501.17 Bn 474.28 Bn 12.70 Bn 3.11 Bn
4 Merck 368.13 Bn 322.51 Bn 12.21 Bn 4.48 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 5.56 Bn
6 Astrazeneca 261.23 Bn 234.92 Bn 12.86 Bn 1.01 Bn
7 Amgen 236.68 Bn 192.08 Bn 7.24 Bn 3.49 Bn
8 Gilead Sciences 190.97 Bn 165.17 Bn 6.22 Bn 3.43 Bn
9 Pfizer 169.72 Bn 116.36 Bn 10.94 Bn 302.00 Mn
10 Innate Pharma 143.35 Mn -63.85 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 829,245.65
API Access

Innate Pharma Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=IPHA&period=max&api_key=YOUR_API_KEY